Balanced pipeline of repurposing and reformulation assets
We reduce clinical risk and time by redirecting approved drugs to new indications and innovating delivery for established therapies.
Repurposing Programs
Approved drug pivoted to new disease
- High value assets with Strong IP protection
- Niche / rare-orphan areas with high unmet need
- Practice-changing blockbuster potential
- Pipeline-in-a-product for specialty partnerships
.gif)
Reformulation Programs
Enhancing proven drugs through optimized delivery
- Low development cost with reduced risk
- Faster commercialization with early partnerships
- High success rates with proven assets
- Broad applicability across therapeutic areas
Partner With Us
At Revio we have the passion & expertise to develop successful drugs that improve patients’ lives & create value for all stakeholders. And we value partnerships that are mutually accretive and help us succeed in our mission.
For Researchers
Have an idea or IP ready for development? Partner with us to turn it into a reality.
For Pharmaceutical and Biotech Companies
Let’s join forces to bring cutting-edge programs to the finish line.
For Investors
Be part of our mission to revolutionize drug development and deliver measurable impact.